Is there any correlation between levels of serum ostepontin, CEA, and FDG uptake in lung cancer patients with bone metastasis?


Ayan A. K., ERDEMCİ B., Orsal E., BAYRAKTUTAN Z., AKPINAR E., Topcu A., ...More

REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, vol.35, no.2, pp.102-106, 2016 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 35 Issue: 2
  • Publication Date: 2016
  • Doi Number: 10.1016/j.remn.2015.09.002
  • Journal Name: REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.102-106
  • Keywords: Lung cancer, Bone metastasis, Positron emission tomography, CEA, OPN, POSITRON EMISSION TOMOGRAPHY, TUMOR-MARKERS, SKELETAL METASTASES, DIAGNOSTIC-VALUE, CYFRA 21-1, OSTEOPONTIN, VARIANTS, PET/CT, ACID
  • Recep Tayyip Erdoğan University Affiliated: Yes

Abstract

Objective: In this study, an evaluation was made of the relationship between the serum levels of carcinoembryonic antigen (CEA), osteopontin (OPN), and the semi-quantitative parameters of 18-fluoro2-deoxyglucose positron emission tomography/computed tomography (F-18-FDG PET/CT) in lung cancer patients with bone metastasis.